141 related articles for article (PubMed ID: 23404110)
1. Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma.
Nutthasirikul N; Limpaiboon T; Leelayuwat C; Patrakitkomjorn S; Jearanaikoon P
Int J Oncol; 2013 Apr; 42(4):1181-8. PubMed ID: 23404110
[TBL] [Abstract][Full Text] [Related]
2. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells.
Nutthasirikul N; Hahnvajanawong C; Techasen A; Limpaiboon T; Leelayuwat C; Chau-In S; Jearanaikoon P
Int J Oncol; 2015 Dec; 47(6):2153-64. PubMed ID: 26459801
[TBL] [Abstract][Full Text] [Related]
3. Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
Marabese M; Marchini S; Marrazzo E; Mariani P; Cattaneo D; Fossati R; Compagnoni A; Signorelli M; Moll UM; Codegoni AM; Broggini M
Eur J Cancer; 2008 Jan; 44(1):131-41. PubMed ID: 18039564
[TBL] [Abstract][Full Text] [Related]
4. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
6. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
7. A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.
Kamlua S; Patrakitkomjorn S; Jearanaikoon P; Menheniott TR; Giraud AS; Limpaiboon T
Oncol Rep; 2012 Apr; 27(4):1207-12. PubMed ID: 22159958
[TBL] [Abstract][Full Text] [Related]
8. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
9. Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver.
Tannapfel A; Engeland K; Weinans L; Katalinic A; Hauss J; Mössner J; Wittekind C
Br J Cancer; 1999 Jun; 80(7):1069-74. PubMed ID: 10362118
[TBL] [Abstract][Full Text] [Related]
10. p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.
Lo Iacono M; Monica V; Saviozzi S; Ceppi P; Bracco E; Papotti M; Scagliotti GV
J Thorac Oncol; 2011 Mar; 6(3):473-81. PubMed ID: 21289519
[TBL] [Abstract][Full Text] [Related]
11. From p63 to p53 across p73.
Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
[TBL] [Abstract][Full Text] [Related]
12. The functional domains in p53 family proteins exhibit both common and distinct properties.
Harms KL; Chen X
Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939
[No Abstract] [Full Text] [Related]
13. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
14. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of p73 overexpression in colorectal carcinoma: a clinicopathologic, immunohistochemical, and statistical study of 204 patients.
Toumi AA; El Hadj Oel A; Ben Mahmoud LK; Ben Hmida Ael M; Chaar I; Gharbi L; Mzabi S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):128-36. PubMed ID: 19956069
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
[TBL] [Abstract][Full Text] [Related]
18. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
[TBL] [Abstract][Full Text] [Related]
19. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
20. p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure.
Gwosdz C; Balz V; Scheckenbach K; Bier H
Adv Otorhinolaryngol; 2005; 62():58-71. PubMed ID: 15608418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
